89Zr-Df-IAB2M
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-Df-IAB2M, covering 2020-02-13 to 2020-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer [Phase 1, Phase 2]